| PERIOD ENDING | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | 30-Jun-07 | | Total Revenue | 3,489,000 | 3,518,000 | 3,549,000 | 3,521,000 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 3,489,000 | 3,518,000 | 3,549,000 | 3,521,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,786,000 | 1,797,000 | 1,739,000 | 1,788,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 774,000 | 819,000 | 763,000 | 746,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 929,000 | 902,000 | 1,047,000 | 987,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 929,000 | 902,000 | 1,047,000 | 987,000 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 929,000 | 902,000 | 1,047,000 | 987,000 | | Income Tax Expense | 265,000 | 252,000 | 309,000 | 278,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 664,000 | 650,000 | 738,000 | 709,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 664,000 | 650,000 | 738,000 | 709,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $664,000 | $650,000 | $738,000 | $709,000 |
|
0.19% Nasdaq 
2.02 (4.24%) 
Income Statement
